These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6183546

  • 1. [Palliative chemotherapy of recurring squamous cell carcinomas of the ENT field with the combination cis-diamminodichloroplatinum (II)/adriamycin].
    Jakse R, Lehnert M, Scherlacher A.
    Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):524-8. PubMed ID: 6183546
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin alone or in combination with adriamycin in the treatment of patients with head and neck cancer relapsed after radiotherapy and/or surgery.
    Villar A, Farrus B, Giner P, Sedano E, Serradell J, de Caralt M.
    Rev Esp Oncol; 1981 Sep; 28(3):395-412. PubMed ID: 6892263
    [Abstract] [Full Text] [Related]

  • 3. [Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
    Jakse R, Scherlacher A, Lehnert M, Haas J.
    HNO; 1986 Jun; 34(6):235-40. PubMed ID: 3744908
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V, Ferraro G, Pergolizzi S, Sergi C, Laudani A, Settineri N, Alafaci E, Scimone A, Spano F, Spitaleri G.
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [Abstract] [Full Text] [Related]

  • 5. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 6. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N, Kitahara S, Tamura E, Tanabe T, Nakanoboh M, Kawada M, Shirasaka T.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 9. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ, Chung JS, Shin HJ, Cho GJ, Wang SG, Lee BJ, Cho BM, Joo YD, Sohn CH.
    J Laryngol Otol; 2008 Aug 15; 122(8):848-53. PubMed ID: 18047761
    [Abstract] [Full Text] [Related]

  • 11. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gedlicka C, Kornfehl J, Turhani D, Burian M, Formanek M.
    Cancer Invest; 2006 Aug 15; 24(3):242-5. PubMed ID: 16809151
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J.
    Cancer; 1999 Dec 01; 86(11):2364-9. PubMed ID: 10590379
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
    Hussain M, Salwen W, Kucuk O, Ensley J.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
    [Abstract] [Full Text] [Related]

  • 14. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.
    Jpn J Clin Oncol; 2009 Apr 01; 39(4):225-30. PubMed ID: 19211574
    [Abstract] [Full Text] [Related]

  • 15. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
    Hanauske AR, Schilling T, Heinrich B, Kau R, Herzog M, Quasthoff S, Bochtler H, Diergarten K, Rastetter J.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 14):35-9. PubMed ID: 8553082
    [Abstract] [Full Text] [Related]

  • 16. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA.
    J Clin Oncol; 2004 Jan 15; 22(2):262-8. PubMed ID: 14722034
    [Abstract] [Full Text] [Related]

  • 17. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Jan 15; 26(1B):585-90. PubMed ID: 16739325
    [Abstract] [Full Text] [Related]

  • 18. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors.
    Gan To Kagaku Ryoho; 2001 Jun 15; 28(6):789-95. PubMed ID: 11432346
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS, Wawro NW, DeConti RC, Kaplan SR, Papac R, Bertino JR.
    Cancer Res; 1968 Jun 15; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract] [Full Text] [Related]

  • 20. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Sandler S, Bonomi P, Taylor B, Showel J, Slayton R, Lerner H.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1163-5. PubMed ID: 6541095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.